A special capsule that shields transplanted insulin-producing cells from a recipient's immune system represents a cost-effective improvement in treatment for diabetes patients. The biomaterials developed and put through preclinical trials by an EU-funded project could also have other applications, such as repairing organs.from EUROPA - Syndicated Research News Feed https://ift.tt/2XNqMS8
via IFTTT
No comments:
Post a Comment